PDS Biotechnology has entered into a licensing agreement with Merck KgaA, Germany, for use of PDS Biotechnology's Versamune nanotechnology platform. Under the terms of the agreement, Merck will obtain the rights to use the technology ...
Tags: Versamune nanotechnology platform, company cooperation
Pfizer Canada has announced the availability of Xalkori (crizotinib) for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC) in Canada. A validated ALK assay should be used to ...
Tags: ALK, ALK-positive lung cancer, Pfizer Canada
Coquette is thrilled to be debuting their first spring/summer collection and introducing a new catalog to their lingerie repertoire. The Spring/Summer 2013 catalog shows their passion for color, textures and femininity. Throughout the ...
Tags: apparel, lingerie industry, Coquette, luxurious lingerie
16 years ago, Lance Armstrong was diagnosed with testicular cancer. In 1997 he started the Lance Armstrong Foundation, which serves people affected by cancer and empowers them to take action against the world's leading cause of death. ...
Tags: Nike, collection, training apparel, celebration
Ann Taylor celebrated the grand opening of its first international store with a chic in-store cocktail together with The Breast Cancer Research Foundation (BCRF). The first Canadian Ann Taylor flagship store is located in the Toronto Eaton ...
Tags: international store, apparel, shopping event, bags
US Department of Defense has granted a Congressionally Directed Medical Research Programs (CDMRP) grant to Aduro BioTech to complete the preclinical development of a new therapeutic cancer vaccine for prostate cancer. Aduro's cancer ...
Tags: Aduro, cancer vaccine platform, IND
US-based Trovagene has developed a urine-based molecular diagnostic test to detect and monitor cancer mutations. The test quantitatively detects KRAS mutations in transrenal DNA,which may be originated from both normal and diseased cells. ...
Tags: Trovagene, molecular diagnostic test, cancer mutations, cancer monitoring
AVEO Oncology and Astellas Pharma have announced FDA acceptance of tivozanib new drug application(NDA)filing for the treatment of advanced renal cell carcinoma(RCC). According to the development and commercialization deal signed between ...
Tags: AVEO Oncology, Astellas Pharma, FDA, RCC, NDA
Sterling Insurance has introduced a new insurance plan, Sterling Critical Condition, to provide lump-sum coverage plans to the insured upon diagnosis of a covered condition. Underwritten by Sterling Life Insurance Company, the plan ...
Tags: Sterling Insurance, insurance plan, lump sum coverage, insurance
Janssen Biotech, a Johnson & Johnson company, has executed a license and development agreement for an investigational anti-cancer agent, daratumumab (HuMax-CD38), with Genmab. Daratumumab is a human CD38 monoclonal antibody which is ...
Tags: Daratumumab License, license and development agreement, anti-cancer
German Cancer Research Center (DKFZ) and Genetic Immunity have joined hands to develop a DNA-based vaccine to treat Human Papilloma Virus (HPV) infection that causes cervical cancer and other cancers of the anus, penis, vulva, vagina and ...
Tags: DKFZ, DNA-based vaccine, HPV, cervical cancer, cancers
TTY Biopharm Co.,Ltd.,a major pharmaceutical maker in Taiwan,recently inaugurated a drug factory in Suzhou,Jiangsu Province of China,operated by TTY`s Chinese subsidiary TOT Biopharm Co.,Ltd. At a cost of about US$100 million,the factory ...
Tags: TTY Biopharm, drug factory, anti-cancer drug injections, Suzhou
Hospira has announced the US re-launch of oxaliplatin injection, a generic version of Sanofi's chemotherapy medication Eloxatin. Hospira will initially offer the solution form of oxaliplatin injection in 50mg and 100mg single-use vials, ...
Tags: oxaliplatin injection, Sanofi's chemotherapy medication, oncology drug
Cancer Therapeutics has announced the validation and performance of CTx-294886 in combination with Avastin in a preclinical model of basal breast cancer. The CTx-0294886, a potent small molecule inhibitor of Focal Adhesion Kinase (FAK) ...
Tags: cancer therapeutics, CTx-294886, basal breast cancer, FAK inhibitor
Skuldtech and AB Science have discovered a new set of blood markers predictive of a higher survival rate in pancreatic cancer patients. The companies are also planning to use the new markers for future companion test commercialization ...
Tags: skuldtech, AB science, blood markers, pancreatic cancer patients